Merck Recalls Cholesterol Drug Liptruzet
Packaging defects have prompted a recall of a combination #cholesterol
drug called #Liptruzet
produced by Merck & Co., temporarily affecting the entire U.S. stock.#Merck
said the foil pouches holding Liptruzet pills could allow air and moisture inside, potentially decreasing the drug's effectiveness.
The recall covers all four dose strengths and every batch that's gone out since Liptruzet hit the market in May.
Liptruzet combines two medications that work together to reduce "bad" cholesterol levels: #Atorvastatin
the generic version of the widely used cholesterol medication #Lipitor
, which reduces the body's natural cholesterol production, and #Zetia
(ezetimibe), a Merck-produced drug that decreases the amount of cholesterol absorbed from food.
Cardiologists expect no health problems to result from the recall, in part because both atorvastatin and Zetia will remain available separately.
Merck said it plans to get Liptruzet back on the market as soon as possible.www.drugs.com/liptruzet.html